Determination of Prevalence and Features of HRRm mCRPC (ADAM)
Condition(s):HRRm mCRPCLast Updated:September 28, 2023Completed
Hide Studies Not Open or Pending
Condition(s):HRRm mCRPCLast Updated:September 28, 2023Completed
Condition(s):mCRPCLast Updated:December 16, 2021Not yet recruiting
Condition(s):Metastatic Castration Resistant Prostate Cancer (mCRPC)Last Updated:March 31, 2022Completed
Condition(s):Metastatic Castration Resistant Prostate CancerLast Updated:August 19, 2019Completed
Condition(s):Metastatic Castrate-Resistant Prostate Cancer (mCRPC)Last Updated:February 6, 2024Recruiting
Condition(s):Prostate Neoplasms; Prostate CancerLast Updated:March 21, 2018Completed
Condition(s):Cancer; Metastatic Castration-resistant Prostate Cancer; mCRPCLast Updated:March 26, 2024Recruiting
Condition(s):mCRPCLast Updated:September 29, 2023Recruiting
Condition(s):Prostatic NeoplasmsLast Updated:February 8, 2017Withdrawn
Condition(s):Metastatic Castration Resistant Prostate CancerLast Updated:July 27, 2020Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.